Pharma

Your Article Summary

See Latest Articles

Forest Laboratories Presents Analysis of Two Positive Pivotal Phase III Studies of Ceftaroline for the Treatment of Community-Acquired Pneumonia at ICAAC
Forest Laboratories, 09/14/09

Forest Laboratories, Inc presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco new data from a complete analysis of FOCUS 1 and FOCUS 2, two global multicenter Phase III studies of ceftaroline for the treatment of community–acquired pneumonia in hospitalized patients.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Myriad Genetics to Present at the 28th Annual J.P. Morgan Healthcare Conference
Myriad, 12/18/09

Covidien plc to Report First-Quarter Results on January 2010
Covidien, 12/17/09

ONC to Explain Community I.T. Project
HealthDataManagement, 12/17/09

 See all of Conferences/Meetings